Dicerna secures $70mm in convertible stock financing
- Antisense, Oligonucleotides
- Large Molecule
- Nanotechnology, Chips, etc.
- Site Specific
- Drug Delivery
- Private Placement
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.